Clough Capital Partners’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-177,085
Closed -$4.92M 164
2017
Q4
$4.92M Sell
177,085
-36,300
-17% -$963K 0.41% 67
2017
Q3
$5.76M Buy
213,385
+31,600
+17% +$827K 0.39% 65
2017
Q2
$5.3M Sell
181,785
-73,000
-29% -$2.22M 0.37% 65
2017
Q1
$8.69M Buy
254,785
+24,200
+10% +$781K 0.55% 57
2016
Q4
$6.99M Buy
230,585
+80,901
+54% +$2.61M 0.46% 65
2016
Q3
$5.06M Sell
149,684
-9,300
-6% -$300K 0.26% 97
2016
Q2
$4.65M Buy
158,984
+92,600
+139% +$2.56M 0.25% 106
2016
Q1
$1.37M Buy
66,384
+9,600
+17% +$236K 0.06% 142
2015
Q4
$1.97M Sell
56,784
-90,800
-62% -$2.61M 0.09% 130
2015
Q3
$3.44M Sell
147,584
-234,516
-61% -$5.7M 0.15% 112
2015
Q2
$6.71M Sell
382,100
-16,500
-4% -$254K 0.26% 100
2015
Q1
$6.12M Buy
398,600
+120,900
+44% +$2.03M 0.2% 125
2014
Q4
$5.03M Buy
+277,700
New +$4.64M 0.18% 122

Other funds holding DERM

Clough Capital Partners's DERM Position: Q1 2018 in Review

Clough Capital Partners sold out of Dermira, Inc. (DERM) in Q1 2018, closing a stake of 177,085 shares — an estimated $4.92M sold.

Clough Capital Partners first reported a position in DERM in Q4 2014 and held it in 13 quarters. The position peaked at $8.69M in Q1 2017. 128 funds tracked by Wall St. Rank hold DERM as of Q1 2018.

  • Clough Capital Partners reported no remaining Dermira, Inc. position as of Q1 2018 after selling out during the quarter.
  • Clough Capital Partners sold 177,085 Dermira, Inc. shares in Q1 2018, an estimated $4.92M.
  • Clough Capital Partners first reported a position in Dermira, Inc. in Q4 2014 and held it in 13 quarters.
  • Clough Capital Partners's Dermira, Inc. position peaked at $8.69M in Q1 2017.
  • 128 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2018.

Based on Clough Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.